| Literature DB >> 29627814 |
Peter Hanlon1, Lynsey Yeoman1, Lauren Gibson2, Regina Esiovwa2, Andrea E Williamson3, Frances S Mair1, Richard Lowrie2.
Abstract
OBJECTIVE: Identify, describe and appraise trials of interventions delivered by healthcare professionals to manage non-communicable diseases (NCDs) and communicable diseases that require long-term care or treatment (LT-CDs), excluding mental health and substance use disorders, in homeless adults.Entities:
Keywords: chronic disease; complex interventions; homelessness; long-term conditions
Mesh:
Year: 2018 PMID: 29627814 PMCID: PMC5892758 DOI: 10.1136/bmjopen-2017-020161
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1PRISMA diagram of search results and screening. ASSIA, Applied Social Science Index and Abstracts; CBA, controlled before-after; CENTRAL, Cochrane Central Register of Controlled Trials; CINAHL, Cumulative Index to Nursing and Allied Health Literature; LT-CD, Communicable disease requiring long-term care; NCD, Non-communicable Disease; NRCT, non-randomised controlled trial; PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses; RCT, randomised controlled trial.
Summary of study populations
| Study | Design | Location | Number of | Age, mean (SD) | Sex (%) | Ethnicity (%) | Condition | Homelessness definition |
| Pilote | RCT | USA | 244 | I1: median 40 | I1: M (71%) | African-American (I1: 48%, I2: 57%, C: 54%) | Latent TB | Homeless: not further defined |
| Tulsky | RCT | USA | 118 | Median 37 | M (89%) | African-American (52%) | Latent TB | Homeless or marginally housed |
| Tulsky | RCT | USA | 141 | Median 41 (range 21–79) | M (85%) | African-American (47%) | Latent TB | Homeless or marginally housed |
| Samet | RCT | USA | 151 (34 homeless) | Median 44 (range 26–60) | M (82%) | n/a | HIV with alcohol problems | Homeless: not further defined |
| Ciaranello | Quasi-experimental | USA | Six transitional housing facilities | I: 41.6 (9.6) | I: M (81%) | n/a | Various | ‘Formerly homeless’ residents of transitional housing |
| Nyamathi | RCT | USA | 520 | 41.5 (8.5) | M (79.6%) | African-American (81%) | Latent TB | Sleeping in homeless shelters |
| Tsai | RCT | USA | 137 | I: median 44 (IQR: 37–53) | I: M (91%) | I: Caucasian (48%) | HIV with comorbid depression | ‘Homeless or marginally housed’ |
| Savage | Randomised | USA | 9 | n/a | n/a | n/a | Type 2 diabetes | Living without shelter or adequate accommodation |
| Tyler | Randomised | USA | 107 (hepatitis C positive subset) | Males: 44 (7.1) | M (79%) | African-American (63%) | Hepatitis C | Homeless: not further specified |
| O’Toole | RCT | USA | 185 | 48.6 (10.8) | M (94%) | ‘Minority population’ (43%) | Various† | ‘Lacking fixed, regular and adequate night-time residence’ |
| Hewett | RCT | UK | 410 | I: 41.6 (12.1) | I: M (81.6%) | N.S. | Various‡ | No fixed residence on hospital discharge |
*Included hypertension, otherwise not fully specified.
†Asthma, COPD, hepatitis, cirrhosis, diabetes, hypertension and arthritis.
‡Categorised by organ system (included liver, pulmonary, musculoskeletal, central nervous system, cardiovascular system, endocrine, skin, gastrointestinal and haematological pathology). Causes for hospital attendance also categorised by aetiology, 35% related to cardiovascular disease and 15% to metabolic conditions.
C, Comparator group; COPD, chronic obstructive pulmonary disease; I, Intervention group; M, male; RCT, randomised controlled trial; TB, tuberculosis.
Risk of bias within individual studies
| Criteria | Study | ||||||||||
| Ciaranello 2006 | Hewett | Nyamathi | O’Toole | Pilote | Samet | Savage | Tsai | Tulsky | Tulsky | Tyler | |
| Random sequence generation | High | Low | Unclear | Low | Unclear | Unclear | High | Low | Low | Low | High |
| Allocation concealment | High | Low | Low | Unclear | Unclear | Unclear | High | Low | Low | Low | Unclear |
| Blinding of participants/personnel | High | High | High | High | High | High | High | High | High | Unclear | High |
| Similar baseline outcome measures | High | Low | Low | Low | Unclear | Low | Unclear | Low | Unclear | Unclear | Low |
| Similar baseline characteristics | High | Low | Low | Low | Low | Low | Unclear | Low | Low | Low | Low |
| Blinding of outcome assessment | High | Low | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | High |
| Incomplete outcome data | High | High | Low | Low | Low | Low | High | Low | Low | Low | Low |
| Protection from contamination | High | Unclear | Low | Unclear | Low | Low | Unclear | Low | Low | Low | Low |
| Selective outcome reporting | High | Low | Low | Low | Low | Unclear | High | Unclear | Low | High | Unclear |
| Other bias | High | Low | Low | Low | Low | Low | High | Low | High | High | Low |
*Assessment based on methods and results as described in the original manuscript. Unpublished data were supplied by authors for secondary analysis of homeless study participants.
Intervention components, theoretical underpinning and outcomes
| Study | Components | Healthcare professional delivering the intervention | Theory | Intervention | Comparator | Outcomes |
| Pilote | Nurse plus peer-health advisor | None specified | Monetary incentive for TB clinic attendance (group 1). Peer-health advisor assisting with clinic attendance (group 2). | Usual care (clinic appointment and tokens for travel expenses) | Attendance at initial TB clinic appointment. | |
| Tulsky | Nurse, outreach worker and peer-health advisor | None specified | Monetary incentive for uptake of DOT (group 1). Peer-health advisor supporting DOT (group 2). | Usual care | Completion of 6 months isoniazid therapy | |
| Tulsky | Nurse, outreach worker and peer-health advisor | None specified | Monetary incentive for uptake of DOT. | Non-cash incentive of equal value (vouchers) | Completion of 6 months isoniazid therapy | |
| Samet | Nurse | Health belief model and motivational interviewing | Adherence support for ART. | Usual care (written instructions/advice regarding treatment adherence) | Adherence to ART | |
| Ciaranello | Medical director, nurse practitioner, medical clerk and social worker | None specified | Weekly visits including health assessment, education, referral and social support. | Transitional houses in a different area not receiving the intervention | ED attendance | |
| Nyamathi | Nurse and outreach worker | Comprehensive health seeking and coping paradigm | DOT plus eight education sessions. Information provided on community resources and participants escorted to appointments. | DOT plus 20 min educational lecture | Completion of directly observed TB therapy | |
| Tsai | Psychiatrist and study nurse | None specified | Directly observed fluoxetine and weekly psychiatric interview | Advice on sources of mental health support | Adherence to antiretroviral therapy | |
| Savage | Nurse | Self-efficacy theory | Nurse-led case-management and diabetes education | Usual care | Self-efficacy | |
| Tyler | Nurse | Comprehensive health seeking and coping paradigm | Case management with group sessions, self-management training and education | Single, brief educational intervention | Hepatitis C knowledge | |
| O’Toole | Nurse | None specified | Nurse-led brief health assessment with motivational interviewing (group 1). Guided orientation to primary care clinic facilities (group 2). Both interventions together (group 3). | Usual care (social work assessment and description of available services) | ED attendance | |
| Hewett | General practitioner and specialist nurse | None specified | Nurse- and GP-led inpatient intervention. Goal setting. Discharge planning. Liaison and multiagency meetings. | Initial meeting with nurse and signposting of services | ED attendance |
ART, antiretroviral treatment; DOT, directly observed therapy; ED, emergency department; GP, general practitioner; TB, tuberculosis.
Figure 2Harvest plot of findings of included studies. CBA, controlled before-after study; NRCT, non-randomised controlled trial; RCT, randomised controlled trial.